PCI术后再狭窄与尿酸及脂联素的关联性研究-国际临床研究杂志-CSCIED科技核心评价数据库-手机版

PCI术后再狭窄与尿酸及脂联素的关联性研究

Study on the relationship between restenosis after PCI and uric acid and adiponectin

ES评分 0 浏览量：742 下载量：0

DOI	10.12208/j.ijcr.20220480
刊名	国际临床研究杂志 International Journal of Clinical Research
年，卷(期)	2022, 6(10)
作者	谷祥任,钱滢,刘俊林*,
作者单位	长沙医学院湖南长沙 ;
摘要	经皮冠状动脉介入治疗（percutaneous coronary intervention，PCI）是治疗冠心病的重要手段之一。然而，随PCI手术的蓬勃开展，PCI术后并发症及复发再狭窄也越来越多，但其复发危险因素尚未明确。本研究主要研究评价了尿酸水平及脂联素水平对冠心病患者PCI术后复发的关联性。研究筛选了81名冠心病患者，对其PCI术前及术后12个月后尿酸水平及脂联素水平进行测定，分析尿酸与脂联素水平与PCI患者复发再狭窄的关联性。结果表明，高尿酸和低脂联素水平可明显增加PCI患者术后复发风险。高尿酸合并低脂联素可使PCI术后风险增加2.46倍，两者联合可作为PCI术后复发的可靠标志物。
Abstract	Percutaneous coronary intervention (PCI) is one of the important means to treat coronary heart disease. However, with the vigorous development of PCI surgery, there are more and more complications and recurrent restenosis after PCI, but the risk factors of recurrence have not been clarified. The purpose of this study was to evaluate the correlation between the level of uric acid and adiponectin in patients with coronary heart disease after PCI. In this study, 81 patients with coronary heart disease were screened, and the levels of uric acid and adiponectin were measured before and 12 months after PCI to analyze the correlation between the levels of uric acid and adiponectin and the recurrence and restenosis of PCI patients. The results showed that high uric acid and low adiponectin levels could significantly increase the risk of recurrence after PCI. High uric acid combined with low adiponectin can increase the risk after PCI by 2.46 times, and the combination of the two can be used as a reliable marker of recurrence after PCI.
关键词	经皮冠状动脉介入治疗；尿酸；脂联素；复发
KeyWord	Percutaneous coronary intervention; uric acid; adiponectin; recurrence
基金项目
页码	82-84

参考文献
相关文献

[1] Li JJ，Xu B，Yang YJ，et al． Drug-eluting stent for the treatment of small coronary lesion: comparison between sirolimus-and paclitaxeleluting stent
[J]． Chin Med J ( Engl) ，2007，120 ( 7) : 569- 573．

[2] Wheeler J G，Juzwishin K D，EiriksdottirG，et al． Serum uric acid and coronary heart disease in 9458 incident cases and 155084 controls: prospective study and meta-analysis
[J]．PLoS Med，2005，2( 3) : 236．

[3] Petersen T S，Madsen T V，Jespersen J B，et al．Uric acid in patients with angiographically documented coronary heart disease
[J]．Acta Cardio，2006，61( 5) : 525．

[4] 艾庆，申强，包忠武，等．血尿酸与冠脉病变程度及心血管事件的关系
[J]．实用临床医药杂志，2013，17( 19) :102．

[5] 丁海峰，马兰，范鹰．高血压病合并高尿酸血症与冠心病的关系
[J]．中国动脉硬化杂志，2011，19( 4) : 339．

[6] 陈慧斐. 冠脉支架植入术后支架内再狭窄的危险因素分析
[J].当代医学，2014，23（20）：12-13

[7] 赵博. 脂肪细胞因子-脂联素的研究进展. 中国城乡企业卫生. 2015. 30(03): 13-16.

引用本文

谷祥任,钱滢,刘俊林*. PCI术后再狭窄与尿酸及脂联素的关联性研究 [J]. 国际临床研究杂志. 2022; 6; (10). 82 - 84.

文献评论

相关学者

相关机构